Institutional Horizontal Shareholdings and Generic Entry in the Pharmaceutical Industry

83 Pages Posted: 10 Dec 2018 Last revised: 20 Mar 2019

See all articles by Joseph Gerakos

Joseph Gerakos

Tuck School of Business at Dartmouth College

Jin Xie

Peking University HSBC Business School

Date Written: March 18, 2019

Abstract

Brand-name pharmaceutical companies often file lawsuits against generic drug manufacturers that challenge the monopoly status of patent-protected drugs. Institutional horizontal shareholdings, measured by the generic shareholders' ownership in the brand-name company relative to their ownership in the generic manufacturer, are significantly positively associated with the likelihood that the two parties enter into a settlement agreement in which the brand pays the generic manufacturer to stay out of the market. Horizontal shareholdings are also positively associated with the brand's daily abnormal stock returns around the settlement agreement. Generic manufacturers who settle with the brand-name company are more likely to delay the sale of generic substitutes if they have higher horizontal shareholdings with the brand-name firm. These delays preclude other generic firms from entering the market.

Keywords: Common ownership; Institutional investor; Product market entry; Pharmaceutical industry; Patent infringement lawsuit; Settlement agreement; Antitrust

JEL Classification: L41, L12, G23, G30

Suggested Citation

Gerakos, Joseph and Xie, Jin, Institutional Horizontal Shareholdings and Generic Entry in the Pharmaceutical Industry (March 18, 2019). Tuck School of Business Working Paper No. 3285161, Available at SSRN: https://ssrn.com/abstract=3285161 or http://dx.doi.org/10.2139/ssrn.3285161

Joseph Gerakos

Tuck School of Business at Dartmouth College ( email )

Hanover, NH 03755
United States

Jin Xie (Contact Author)

Peking University HSBC Business School ( email )

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
424
Abstract Views
4,165
Rank
122,912
PlumX Metrics